|
|
Harmony Biosciences Holdings inc (HRMY) |
|
|
|
Harmony Biosciences Holdings Inc 's Yearly Free Cash Flow Growth 5 Years |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
HRMY Annual Free Cash Flow Growth |
2023
|
2022
|
2021
|
2020
|
|
Y / Y Annual Free Cash Flow Change |
51.64 % |
47.03 % |
- |
- |
- |
Annual Free Cash Flow (in millions $) |
$219.08 |
$144.47 |
$98.26 |
$-2.99 |
$0.00 |
Annual Free Cash Flow Growth
Comment |
Harmony Biosciences Holdings Inc 's Annual Free Cash Flow for the fiscal year ended 2023, soared by 51.64% to $219.08 millions, from $144.47 millions achieved a year ago. Harmony Biosciences Holdings Inc 's growrh rate for Free Cash Flow improved from 47.03 % increase in the fiscal year 2022.
Harmony Biosciences Holdings Inc Annual Income Statement
|
You need to upgrade your Flash Player
|
Companies with similar 2023 Annual Free Cash Flow within Healthcare Sector | Y/Y Free Cash Flow Growth % | 2023 Annual Free Cash Flow | Hologic Inc | -53.32 % | $ 959.400 millions | Vir Biotechnology Inc | | | |